Concepedia

Shai Erlich

SE

Statistics

Publications

12

Citations

1.4K

H-Index

12

Active since

1995

Affiliations

Quark Pharmaceuticals (United States)(Current)

Icahn School of Medicine at Mount Sinai

Indiana University School of Medicine

Indiana University

Pfizer (United States)

Shai Erlich is an author at Quark Pharmaceuticals (United States) specializing in medicine, immunology, and lysosomal storage disease.

ORCID

Top concepts

Publications per year

1995–2021

12

Publications

12

Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease

Kenichi Horinouchi, Shai Erlich, Daniel P. Perl et al. · Nature Genetics · 1995 · 476 citations

, , +9

siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury

Bruce A. Molitoris, Pierre C. Dagher, Ruben M. Sandoval et al. · Journal of the American Society of Nephrology · 2009 · 337 citations · Full text

, , +14

Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Investigative Ophthalmology & Visual Science · 2012 · 99 citations

Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study

Matthias Thielmann, David Corteville, Gábor Szabó et al. · Circulation · 2021 · 90 citations · Full text

Toxicological and Pharmacokinetic Properties of Chemically Modified siRNAs Targeting p53 RNA Following Intravenous Administration

James D. Thompson, Douglas J. Kornbrust, Jeffrey W.-D. Foy et al. · Nucleic Acid Therapeutics · 2012 · 84 citations

, , +17

Rows per page

1–5 of 12